Skip to main content
. 2012 Feb 8;7(2):e31188. doi: 10.1371/journal.pone.0031188

Figure 9. LOX-PP inhibits Ras effector Erk1/2 phosphorylation in vivo.

Figure 9

Western blot analysis of 42 and 44 kDa phospho-Erk, total Erk1/2 and 36 kDa beta-actin from tumor extracts after (A) direct i.t. injections of rLOX-PP (L) compared to PBS (P); (B) after implantation of empty (EB) and rLOX-PP (LB) alginate beads; (C) the corresponding quantifications are shown (*, p<0.05; nā€Š=ā€Š3).